Status:
COMPLETED
Stress Reduction in the Prevention of Left Ventricular Hypertrophy
Lead Sponsor:
Maharishi International University
Collaborating Sponsors:
Charles Drew University of Medicine and Science
Conditions:
Left Ventricular Hypertrophy
High Blood Pressure
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
This study evaluated the effect of stress reduction by Transcendental Meditation (TM) on left ventricular mass compared to a health education control group in pre-hypertensive or hypertensive African-...
Detailed Description
Left ventricular hypertrophy (LVH) is an independent risk factor for cardiovascular disease (CVD). African Americans have higher rates of LVH and CVD than whites. Substantial evidence indicates that p...
Eligibility Criteria
Inclusion
- self-identified African-American men and women ages, 20-75 years old, with either prehypertension (systolic blood pressure (SBP) of 120-139 mm Hg and/or diastolic blood pressure (DBP) of 80-89 mm Hg), Stage-1 hypertension (SBP of 140-159 mm Hg and/or DBP of 90-99 mm Hg) or Stage-2 hypertension (SBP of 160-179 and/or DBP of 100-109 mm of Hg), with or without antihypertensive medications -
Exclusion
- Patients with a history of stroke, transient cerebral ischemic attack, congestive heart failure, myocardial infarction, angina pectoris or with significant ECG abnormalities, major psychiatric or behavioral disorder such as alcoholism (\> 28 drinks per week)
- \-
Key Trial Info
Start Date :
April 1 1996
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 1998
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT05373732
Start Date
April 1 1996
End Date
December 1 1998
Last Update
May 13 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.